Cancer Stem Cells & EMT: Mechanisms of Metastasis

Added:

EMT-Independent Metastasis and Tumor Cell Plasticity

While Robert Weinberg's model posits that Epithelial-Mesenchymal Transition (EMT) is a prerequisite for metastasis and the acquisition of cancer stem cell (CSC) properties, opposing research challenges its indispensability. Lineage-tracing studies in pancreatic and breast cancers have demonstrated that metastasis can occur even when key EMT transcription factors are genetically suppressed. This counter-perspective suggests that cancer cells often migrate collectively as cohesive epithelial clusters rather than undergoing individual mesenchymal transition. Furthermore, critics of the rigid CSC model champion a highly fluid 'phenotypic plasticity' framework. In this view, stemness is not a hardwired intrinsic state triggered solely by EMT, but a transient, reversible state that can be adopted by almost any cancer cell in response to microenvironmental cues. This challenges the strict hierarchical necessity of the EMT-CSC program in metastatic progression.

Fundamental principles of oncology, including the multi-step progression of cancer and the classic hallmarks of cancer.
Basic cell biology concepts regarding epithelial and mesenchymal cell types, specifically their differences in cell polarity, adhesion, and motility.
The core concepts of stem cell biology, such as self-renewal, differentiation pathways, and asymmetric cell division.
An overview of the metastatic cascade, specifically how primary tumor cells disseminate to and colonize distant organs.
The process of Mesenchymal-to-Epithelial Transition (MET) and its necessity for metastatic colonization at secondary sites.
The specific transcription factors (such as SNAIL, SLUG, and TWIST) and signaling pathways (such as TGF-beta, Wnt, and Notch) that orchestrate EMT.
Therapeutic strategies aimed at targeting cancer stem cells and inhibiting EMT to overcome drug resistance and prevent tumor recurrence.
The role of the tumor microenvironment (TME) and stromal cell interactions in inducing and maintaining the EMT phenotype in cancer cells.
29.9K views391likes1:04:53@salkinstituteOriginal Release: 2016-04-15

The epithelial-mesenchymal transition (EMT) is an epigenetic cell biological program, not a genetic mutation, that enables cancer cells to acquire the ability to metastasize; this program allows cells to transition from epithelial to mesenchymal states, with cancer stem cells residing at an intermediate position on this spectrum, and its activation alone is sufficient to propel cells from primary tumors to distant metastatic sites, challenging the traditional view that metastasis requires specific genetic mutations.